- ￥1338 - 9188
- abinScience
- France
- VK740023
- 2026年09月03日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
12 months
- 英文名：
Anti-ZIKV Envelope protein E/DIII domain Recombinant Antibody (ZV-64)
- 供应商：
武汉研升生物科技有限公司
- 规格：
50μg/100μg/1mg
| 规格： | 50μg | 产品价格： | ￥1338.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥2288.0 |
| 规格： | 1mg | 产品价格： | ￥9188.0 |
| 产品名称 | Anti-ZIKV Envelope protein E/DIII domain Recombinant Antibody (ZV-64) |
| 货号 | VK740023 |
| 反应种属 | Zika virus (ZIKV) |
| 应用实验 | ELISA, FCM, SPR |
| 宿主/表达体系 | Mouse |
| 靶点 | Capsid protein, Capsid protein C, Core protein, EC:2.1.1.56, EC:2.1.1.57, EC:2.7.7.48, EC:3.4.21.91, EC:3.6.1.15, EC:3.6.4.13, Envelope protein E, Flavivirin protease NS2B regulatory subunit, Flavivirin protease NS3 catalytic subunit, Genome polyprotein, Matrix protein, NS1, NS2A, NS4A, NS4B, NS5, Non-structural protein 1, Non-structural protein 2A, Non-structural protein 2B, Non-structural protein 3, Non-structural protein 4A, Non-structural protein 4B, Peptide 2k, Peptide pr, Peptide precursor, Precursor membrane protein, Protein prM, RNA-directed RNA polymerase/Methyltransferase NS5, Serine protease NS3, Serine protease subunit NS2B, Small envelope protein M |
| 基因号 | Q32ZE1 |
| 状态 | Liquid |
| 纯度 | >95% as determined by SDS-PAGE. |
| 储存温度 | -20℃ |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Intracellular Antibody Capture (IAC) Methods for Single Domain Antibodies
Intracellular single domain antibodies are recombinant proteins, comprising one variable region domain fragment, that bind specifically to intracellular molecules and can interfere with their particular functions within various cellular
Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
A growing number of recombinant antibodies is being developed for immunotherapy of cancer (1 ,2 ) (see also Chapter 2 ). Although these recombinant antibodies can exhibit a potent anti-tumoral activity in vitro, efficacy in vivo
Expression and Isolation of Recombinant Antibody Fragments in E. coli
Central to the rapid growth in the study and application of recombinant antibodies in recent years is the ability to reliably and cost-effectively produce large quantities of functional protein. In contrast to glycosylated whole monoclonal
技术资料暂无技术资料 索取技术资料
